• Suche
Universität Basel
Departement 
Pharmazeutische Wissenschaften
Departement
Pharmazeutische Wissenschaften
  • Suche
  • Management
  • Research Groups
  • Teaching
  • News & Events
  • Contact
  • Biopharmacy
  • Clinical Pharmacology & Toxicology
  • Clinical Pharmacy & Epidemiology
  • Computational Pharmacy
  • Molecular & Systems Toxicology
  • Molecular Pharmacy
  • Pharmaceutical Biology
  • Pharmaceutical Care
  • Pharmaceutical Technology
  • Regulatory Toxicology
  • BSc Pharm. Wissenschaften
  • MSc Pharmazie
  • MSc Drug Sciences
  • Doctorate/PhD
  • SDS (Seminars on Drug Sciences)
  • Weiterbildung Pharmazie
  1. pharma.unibas.ch
  2. Research Groups
  3. Pharmaceutical Technology
  4. Research
  5. öffnen / schliessen
  • Drug Targeting
  • Drug Delivery

Drug Targeting

A big progress in nanomedicine was made during the last decade. Nanomedicines based on inorganic materials, lipids and natural or synthetic polymers were prepared and reached approval by health care authorities. Nanoparticles (NPs) can have inherent therapeutic effects (e.g. induction of oxidative stress or DNA damage), can be used as drug carriers, and can further be used as imaging agents or theranostics. Although the principles of nanomedicine are applicable to a broad range of diseases, treatment of cancer remains the most advanced therapeutic field (summarized in Wicki et al., 2015).
In our group, we use a broad range of nanomaterials for passive and active drug targeting and for imaging and test these systems in various in vitro and in vivo settings.

Drug Delivery

Modern drug delivery requires a versatile approach when designing and manufacturing dosage forms. Research in the field of classical pharmaceutical technology is constantly challenged by new targets, new substances, various delivery routes, and manufacturing requirements. Modern pharmaceutical technology combines the use of novel techniques and instruments with biological as well as health-related discoveries. Research projects in the field of drug delivery are combining material science to identify new excipients with modern approaches in formulation design, such as computer-based simulations, and clinical R&D.

Our vision is to propose robust strategies to move towards personalized medicine, age appropriate and safe formulations, and increase in patient’s compliance.

Selected Publications

Drug Targeting

  • Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications
  • Comparative safety evaluation of silica-based particles
  • Zebrafish as an early stage screening tool to study the systemic circulation of nanoparticulate drug delivery systems in vivo

Drug Delivery

  • Drug loading into porous calcium carbonate microparticles by solvent evaporation
  • In vitro characterization and mouthfeel study of functionalized calcium carbonate in orally disintegrating tablets
  • CombiCap: A novel drug formulation for the basel phenotyping cocktail
Nach oben
  • © Universität Basel
  • Impressum
  • Contact